These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 16083538

  • 21. Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings.
    Tohda Y, Miyamoto T.
    Curr Med Res Opin; 2010 Jan; 26(1):203-12. PubMed ID: 19921960
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
    LaForce CF, Pearlman DS, Ruff ME, Silvers WS, Weinstein SW, Clements DS, Brown A, Duke S, Harding SM, House KW.
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
    [Abstract] [Full Text] [Related]

  • 23. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study.
    Krouse JH, Krouse HJ, Janisse JJ.
    Clin Drug Investig; 2009 Nov; 29(1):51-8. PubMed ID: 19067474
    [Abstract] [Full Text] [Related]

  • 24. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
    Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE.
    J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706
    [Abstract] [Full Text] [Related]

  • 25. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG, Mendelson LM, Pearlman DS.
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [Abstract] [Full Text] [Related]

  • 27. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P, Creemers JP, Vondra V, Black PN, Lindqvist A, Nihlen U, Vogelmeier C.
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [Abstract] [Full Text] [Related]

  • 28. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH, Howland WC, Lumry WR.
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
    [Abstract] [Full Text] [Related]

  • 29. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG.
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P, Jagannath K, Joshi JM, Awad N, Boss H, Hellbardt S, Gadgil DA.
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

  • 32. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.
    Noonan M, Leflein J, Corren J, Staudinger H.
    BMC Pediatr; 2009 Jul 13; 9():43. PubMed ID: 19594937
    [Abstract] [Full Text] [Related]

  • 33. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children.
    White MV, Cruz-Rivera M, Walton-Bowen K.
    Fam Med; 1999 May 13; 31(5):337-45. PubMed ID: 10407712
    [Abstract] [Full Text] [Related]

  • 34. Comparison of mometasone furoate administered by metered dose inhaler with beclomethasone dipropionate.
    Chervinsky P, Nelson HS, Bernstein DI, Berkowitz RA, Siegel SC.
    Int J Clin Pract; 2002 May 13; 56(6):419-25. PubMed ID: 12166539
    [Abstract] [Full Text] [Related]

  • 35. One-year treatment with mometasone furoate in chronic obstructive pulmonary disease.
    Calverley PM, Rennard S, Nelson HS, Karpel JP, Abbate EH, Stryszak P, Staudinger H.
    Respir Res; 2008 Nov 13; 9(1):73. PubMed ID: 19014549
    [Abstract] [Full Text] [Related]

  • 36. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study.
    Price D, Robertson A, Bullen K, Rand C, Horne R, Staudinger H.
    BMC Pulm Med; 2010 Jan 05; 10():1. PubMed ID: 20051135
    [Abstract] [Full Text] [Related]

  • 37. A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma.
    Ramsdell JW, Fish L, Graft D, Higgins N, Kavuru M, Pleskow W, Banerji D.
    Ann Allergy Asthma Immunol; 1998 May 05; 80(5):385-90. PubMed ID: 9609607
    [Abstract] [Full Text] [Related]

  • 38. The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma.
    Meltzer EO, Wenzel S.
    J Asthma; 2006 Dec 05; 43(10):765-72. PubMed ID: 17169829
    [Abstract] [Full Text] [Related]

  • 39. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT, Benezet O, Kafé H, Ponitz HH, Cheung D, Engelstätter R, Barnes PJ.
    Clin Ther; 2006 Jun 05; 28(6):906-20. PubMed ID: 16860173
    [Abstract] [Full Text] [Related]

  • 40. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis.
    Kosoglou T, Cutler DL, Staudinger H, Herron JM.
    Chest; 2010 Jan 05; 137(1):115-21. PubMed ID: 19749003
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.